These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 27045586

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. MiR-155 affects proliferation and apoptosis of bladder cancer cells by regulating GSK-3β/β-catenin pathway.
    Dong ZC, Zhang D, Zhang XX, Yao ZQ, Wu H, Chen CH, Tian JQ.
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5682-5690. PubMed ID: 31298320
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. miR-141 confers docetaxel chemoresistance of breast cancer cells via regulation of EIF4E expression.
    Yao YS, Qiu WS, Yao RY, Zhang Q, Zhuang LK, Zhou F, Sun LB, Yue L.
    Oncol Rep; 2015 May; 33(5):2504-12. PubMed ID: 25813250
    [Abstract] [Full Text] [Related]

  • 28. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.
    Luo M, Hou L, Li J, Shao S, Huang S, Meng D, Liu L, Feng L, Xia P, Qin T, Zhao X.
    Cancer Lett; 2016 Apr 01; 373(1):1-11. PubMed ID: 26805761
    [Abstract] [Full Text] [Related]

  • 29. Caspase-dependent and caspase-independent induction of apoptosis in breast cancer by fucoidan via the PI3K/AKT/GSK3β pathway in vivo and in vitro.
    Xue M, Ji X, Xue C, Liang H, Ge Y, He X, Zhang L, Bian K, Zhang L.
    Biomed Pharmacother; 2017 Oct 01; 94():898-908. PubMed ID: 28810530
    [Abstract] [Full Text] [Related]

  • 30. The miR-203/SNAI2 axis regulates prostate tumor growth, migration, angiogenesis and stemness potentially by modulating GSK-3β/β-CATENIN signal pathway.
    Tian X, Tao F, Zhang B, Dong JT, Zhang Z.
    IUBMB Life; 2018 Mar 01; 70(3):224-236. PubMed ID: 29389061
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. MicroRNA-452 contributes to the docetaxel resistance of breast cancer cells.
    Hu Q, Chen WX, Zhong SL, Zhang JY, Ma TF, Ji H, Lv MM, Tang JH, Zhao JH.
    Tumour Biol; 2014 Jul 01; 35(7):6327-34. PubMed ID: 24648265
    [Abstract] [Full Text] [Related]

  • 38. MiR-124 regulates osteoblast differentiation through GSK-3β in ankylosing spondylitis.
    Tang SL, Huang QH, Wu LG, Liu C, Cai AL.
    Eur Rev Med Pharmacol Sci; 2018 Oct 01; 22(20):6616-6624. PubMed ID: 30402833
    [Abstract] [Full Text] [Related]

  • 39. A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancer.
    Kim do Y, Park EY, Chang E, Kang HG, Koo Y, Lee EJ, Ko JY, Kong HK, Chun KH, Park JH.
    Oncotarget; 2016 Mar 22; 7(12):14791-802. PubMed ID: 26895471
    [Abstract] [Full Text] [Related]

  • 40. MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel.
    Zhang HD, Sun DW, Mao L, Zhang J, Jiang LH, Li J, Wu Y, Ji H, Chen W, Wang J, Ma R, Cao HX, Wu JZ, Tang JH.
    Biochem Biophys Res Commun; 2015 Oct 02; 465(4):702-13. PubMed ID: 26299922
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.